Hair Loss Despite Minoxidil Why It Happens and What to Do
Seeing ongoing thinning after starting minoxidil can feel frustrating, especially when treatment is being used correctly. The key point is that minoxidil can support hair growth, but it does not address every driver of hair loss. In androgenetic alopecia, often called male or female pattern hair loss, genetics, hormones, follicle sensitivity, health factors and time all matter.
This article explains why hair loss despite minoxidil can happen, how DHT fits into the picture, and when a professional review is sensible. It is educational only and does not replace individual medical advice.

How minoxidil supports the hair growth cycle
Minoxidil is used topically as a solution or foam, and in some cases prescribed orally at low dose under medical supervision. For pattern hair loss, topical minoxidil is widely used and supported by clinical experience and research.
Hair follicles move through a cycle:
Anagen The active growth phase
Catagen A short transition phase
Telogen The resting and shedding phase
Minoxidil appears to help by encouraging follicles to stay in or re-enter the growth phase. It may also improve blood flow around follicles and influence cellular signals involved in hair growth. The exact mechanism is not fully understood, but the practical aim is to increase visible hair density or slow shedding in responsive follicles.
The important limitation is this: minoxidil does not directly block dihydrotestosterone, better known as DHT. That is why the relationship between minoxidil and DHT is central to understanding ongoing thinning.
The role of DHT in pattern hair loss
DHT is made from testosterone by an enzyme called 5-alpha reductase. In people genetically prone to pattern hair loss, some scalp follicles are more sensitive to DHT.
Over time, DHT can contribute to follicular miniaturisation. This means affected follicles produce hairs that become:
Finer
Shorter
Lighter in colour
Less able to grow for long periods
This process often shows as recession at the temples, thinning at the crown, widening of the parting or reduced density across the top of the scalp.
Minoxidil may help miniaturised follicles perform better, but it does not remove the hormonal pressure that may be contributing to miniaturisation. So hair loss can still progress in some people, particularly if DHT sensitivity is a major factor.
DHT is not the only possible cause. Iron deficiency, thyroid disease, significant stress, illness, medicines, scalp inflammation and nutritional problems can all contribute to shedding or thinning. This is one reason assessment matters when the pattern is unclear.
Minoxidil, finasteride and dutasteride work differently
A common question is finasteride vs minoxidil, and whether one is “stronger”. A better way to think about them is that they target different parts of the process.
Treatment | Main action | Potential benefit | Key risks and considerations |
Minoxidil | Supports the hair growth cycle and may prolong growth phase | Can improve density and reduce shedding in some users | Scalp irritation, unwanted facial hair if it spreads, initial shedding, needs ongoing use |
Finasteride | Reduces conversion of testosterone to DHT, mainly by inhibiting type II 5-alpha reductase | May slow DHT-related miniaturisation and support regrowth in suitable patients | Not suitable for everyone. Possible sexual side effects, mood-related concerns in some users, pregnancy handling precautions |
Dutasteride | Reduces DHT more broadly by inhibiting type I and type II 5-alpha reductase | May reduce DHT more than finasteride, sometimes considered when appropriate | Longer-lasting effects, similar side effect considerations, prescribing is more specialist and individualised |
UK clinical guidance, including NICE Clinical Knowledge Summaries, recognises topical minoxidil and oral finasteride as treatment options for androgenetic alopecia in appropriate patients. Dermatology reviews and peer-reviewed studies also support these mechanisms, though response varies.
No treatment guarantees regrowth. The right option depends on sex, age, medical history, pregnancy potential, side effect tolerance, hair loss pattern and personal preference.

Why minoxidil may not work as expected
Use has not been consistent enough
Minoxidil generally needs regular, long-term use. Missed applications, stopping and restarting, applying too little, or washing it off too soon can reduce the chance of benefit.
For topical products, the scalp should usually be dry before application. It also matters that the product reaches the scalp, not just the hair.
The timeline may be too short
Hair grows slowly. Many people expect visible change within weeks, but meaningful assessment usually takes several months. Early shedding can also happen when follicles shift into a new growth cycle. This can feel alarming, but it is a recognised effect and does not always mean treatment is failing.
If shedding is severe, prolonged or accompanied by scalp symptoms, it should be reviewed.
The follicles may not respond strongly
Some people are strong responders. Others see stabilisation rather than regrowth, and some see little benefit. This variation is seen across clinical practice and research. Genetics, duration of hair loss and the degree of miniaturisation can all affect response.
Follicles that have been inactive for a long time may be less likely to recover fully.
DHT-related miniaturisation may still be progressing
Because minoxidil does not lower DHT, hair thinning can continue if androgen sensitivity remains active. This is why some treatment plans combine a growth-supporting treatment with a DHT-reducing medicine, when clinically appropriate.
The diagnosis may be incomplete
Not all shedding is pattern hair loss. Other causes include:
Telogen effluvium after illness, stress, surgery, rapid weight loss or childbirth
Low ferritin or iron deficiency
Thyroid disease
Alopecia areata
Seborrhoeic dermatitis or psoriasis affecting the scalp
Traction from tight hairstyles
Medicine-related shedding
Treating the wrong condition with minoxidil alone can lead to disappointment and delayed care.
When to seek professional assessment
A review is sensible if hair loss is sudden, patchy, painful, associated with scaling or redness, or progressing despite consistent treatment. It is also worth seeking advice if thinning affects confidence, treatment side effects occur, or you are unsure whether the pattern fits androgenetic alopecia.
A clinician may assess the scalp, review medicines and health history, check the pattern of loss and consider blood tests where appropriate. This can help decide whether minoxidil alone is reasonable, whether a DHT-targeting treatment is suitable, or whether another diagnosis needs treatment.
FAQs
Does minoxidil block DHT?
No. Minoxidil supports the hair growth cycle but does not directly block DHT or reduce its production. Finasteride and dutasteride work differently by reducing DHT production.
Can hair loss continue while using minoxidil?
Yes. Hair loss can continue if DHT-related miniaturisation is progressing, use is inconsistent, the response is limited, or another cause of shedding is present.
Can minoxidil be combined with finasteride or dutasteride?
In some cases, yes. Combination treatment may be appropriate because the medicines target different mechanisms. Suitability depends on medical history, side effect risks and individual circumstances, so it should be discussed with a qualified prescriber.
What happens when minoxidil is stopped?
Any hairs being maintained by minoxidil may gradually shed after stopping. The underlying hair loss pattern may then become more visible again over time.
Key takeaway
Minoxidil can be useful for pattern hair loss, but it is not a DHT blocker and it does not treat every cause of thinning. If hair loss continues despite careful, consistent use, the next step is not to assume failure. It is to check the diagnosis, timeline, technique and whether a different or combined approach is clinically appropriate.



